Idiopathic Parkinson's disease
Showing 1 - 25 of >10,000
HRQoL in Parkinson's Disease Patients Patients: Role of Social
Completed
- Parkinson Disease
- +5 more
-
Columbus, OhioThe Ohio State University
Oct 10, 2022
Idiopathic Parkinson Disease Trial (MRx0029, MRx0005)
Withdrawn
- Idiopathic Parkinson Disease
- MRx0029
- MRx0005
- (no location specified)
Apr 19, 2023
Parkinson Disease Trial (NeuraLight)
Not yet recruiting
- Parkinson Disease
- NeuraLight
- (no location specified)
May 17, 2023
Idiopathic Parkinson's Progression and Dopamine Transporter
Completed
- Parkinson Disease
- Ioflupane I 123
-
Lexington, KentuckyUniversity of Kentucky Department of Neurology
Nov 16, 2022
Parkinson Disease Trial (NeuraLight)
Not yet recruiting
- Parkinson Disease
- NeuraLight
- (no location specified)
Mar 29, 2023
Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)
Not yet recruiting
- Idiopathic Parkinson's Disease
- hAESCs
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jan 28, 2023
Parkinson's Disease Trial in San Francisco, Chicago (CERE-120: AAV2-NTN)
Completed
- Parkinson's Disease
- CERE-120: AAV2-NTN
-
San Francisco, California
- +1 more
Nov 8, 2022
Fatigue, Sleep and Quality of Life in Parkinson's Patients
Recruiting
- Idiopathic Parkinson's Disease
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 18, 2023
DBS-FOAR Syndrome, PD Trial in China (Directional deep brain stimualtion)
Active, not recruiting
- DBS-FOAR Syndrome
- PD
- Directional deep brain stimualtion
-
Beijing, China
- +8 more
Aug 14, 2023
Idiopathic Parkinson Disease Trial in Petach Tikva (NeuraLight software-based platform)
Recruiting
- Idiopathic Parkinson Disease
- NeuraLight software-based platform
-
Petach Tikva, IsraelRabin Medical Center
Aug 14, 2022
Idiopathic Parkinson's Disease Trial in United States (CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]), Sham
Completed
- Idiopathic Parkinson's Disease
- CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])
- Sham Surgery
-
Birmingham, Alabama
- +8 more
Nov 8, 2022
Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy
Recruiting
- Tremor Associated With Tremor Dominant Parkinson's Disease
- Unilateral thalamotomy
-
Chicago, Illinois
- +1 more
Aug 1, 2022
Balance, Activity-specific Balance Confidence and Quality of
Recruiting
- Idiopathic Parkinson's Disease
- Assessment
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 8, 2023
Idiopathic Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in León (Adipose-derived stromal vascular fraction
Completed
- Idiopathic Parkinson Disease
- Parkinson's Disease and Parkinsonism
- Adipose-derived stromal vascular fraction cells
-
León, Leon, NicaraguaHospital Escuela Oscar Danilo Rosales Arguello
Jan 24, 2023
Movement Disorders, Neurology, Parkinsons Disease Trial (Exablate Pallidotomy, Unilateral)
Not yet recruiting
- Movement Disorders
- +2 more
- Exablate Pallidotomy, Unilateral
- (no location specified)
Sep 13, 2022
Idiopathic Parkinson's Disease Trial (Aadipose-Derived Mesenchymal Stem Cells)
Not yet recruiting
- Idiopathic Parkinson's Disease
- Aadipose-Derived Mesenchymal Stem Cells
- (no location specified)
Jan 20, 2022
Parkinson's Disease Trial in Charlottesville (ExAblate Transcranial System)
Active, not recruiting
- Parkinson's Disease
- ExAblate Transcranial System
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022
Parkinson Disease, Idiopathic Parkinson Disease Trial in Philadelphia (Intravenous and Oral n-acetyl cysteine)
Active, not recruiting
- Parkinson Disease
- Idiopathic Parkinson Disease
- Intravenous and Oral n-acetyl cysteine
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jul 11, 2022
Measuring Parkinson's Disease With Tear Fluid
Completed
- Idiopathic Parkinson Disease
-
Los Angeles, CaliforniaUniversity of Southern California
May 5, 2022
Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,
Not yet recruiting
- Idiopathic Parkinson Disease
- levodopa/carbidopa oral formulation A
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Jul 20, 2022
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Mitochondrial and Peroxisomal Metabolism to Differentiate
Recruiting
- Idiopathic Parkinson Disease
- Parkinsonian Syndrome
- blood collection
-
Dijon, FranceChu Dijon Bourgogne
Oct 26, 2021
Idiopathic Parkinson's Disease, Progressive Supranuclear Palsy Trial in Cassino (FR), Rome (Foot Mechanical Stimulation
Terminated
- Idiopathic Parkinson's Disease
- Progressive Supranuclear Palsy
- Foot Mechanical Stimulation (GONDOLA)
-
Cassino, FR, Italy
- +2 more
Sep 30, 2022
Idiopathic Parkinson Disease, Telerehabilitation, Physical Therapy Trial in Stockholm (Motor-cognitive exercise therapy in the
Completed
- Idiopathic Parkinson Disease
- +2 more
- Motor-cognitive exercise therapy in the home
-
Stockholm, SwedenStockholms Sjukhem
May 3, 2022